Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Bio-Techne (TECH) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareBiotechnologyTECH

Closing price · Nov 19, 2026 $72.71 -0.1% on the day · +26.3% over 12 months 52-week range $43.17 – $72.80
Get TECH alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling1last 12 months
Reported sales$437K0 of 2 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
Latest open-market trade

Sale Amy E. Herr, Director sold 6,636 shares at $48.28 ($320K).

Trade date
May 8, 2026
Disclosed to the SEC
May 12, 2026
Type
Sale (code S)

Read the original SEC filing ↗All TECH insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

TECH insider transactions (Form 4)

Open-market purchases and sales. 78 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
May 12SEC Amy E. HerrDirector Sell 6,636200 held (−97%) $48.28 $320K +50.6% —
Feb 19SEC Amy E. HerrDirector Sell 1,976200 held (−91%) $59.10 $117K +23.0% —
Historical context

Similar past setups: not applicable. TECH has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with TECH in the Research Lab

TECH has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

TECH closeInsider buyInsider sale
4050607080DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-05-06EEarnings release filed 2026-08-12Sold $116,791 on 2026-02-17 · Amy E. HerrSold $320,386 on 2026-05-08 · Amy E. Herr
Bought, 12 months$0
Sold, 12 months$437K
Insiders buying0
Insiders selling1

Bio-Techne insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 1 sold $437K of TECH stock on the open market; P/E 66.8 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

TECH insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $117K sold (1 trades)Q1 2026Q2 2026: $320K sold (1 trades)Q2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026—0$320K1
Q1 2026—0$117K1

Valuation, profit and volume

P/E (trailing)66.8Sector median 25.0
Market value$11.43BBiotechnology
Profit margin14.0%Revenue growth +4.6%
Volume vs. 50-day1.2×Last 5 sessions

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Bio-Techne insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $437K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

TECH earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 12, 2026 +0.7% None +0.0%S&P +0.9% +0.0%
May 6, 2026 -6.4% None -10.2%S&P +1.1% +2.3%
Feb 4, 2026 -5.9% None +1.9%S&P -1.7% -18.1%
Nov 5, 2025 -2.3% None -4.8%S&P -0.7% +6.2%
Aug 6, 2025 +8.7% None -8.2%S&P +0.7% +8.7%
May 7, 2025 +0.4% None +4.3%S&P +1.1% -2.0%
Feb 5, 2025 -4.3% None +3.4%S&P +0.8% -14.1%
Oct 30, 2024 -4.2% None +4.3%S&P -2.3% +2.3%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

TECH short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 42% of volume sold short2026-08-27: 67% of volume sold short2026-08-28: 53% of volume sold short2026-08-31: 43% of volume sold short2026-09-01: 50% of volume sold short2026-09-02: 37% of volume sold short2026-09-03: 30% of volume sold short2026-09-04: 23% of volume sold short2026-09-08: 42% of volume sold short2026-09-09: 45% of volume sold short2026-09-10: 45% of volume sold short2026-09-11: 39% of volume sold short2026-09-14: 27% of volume sold short2026-09-15: 25% of volume sold short2026-09-16: 14% of volume sold short2026-09-17: 11% of volume sold short2026-09-18: 52% of volume sold short2026-09-21: 10% of volume sold short2026-09-22: 12% of volume sold short2026-09-23: 21% of volume sold short2026-09-24: 11% of volume sold short2026-09-25: 26% of volume sold short2026-09-28: 13% of volume sold short2026-09-29: 35% of volume sold short2026-09-30: 47% of volume sold short2026-10-01: 40% of volume sold short2026-10-02: 32% of volume sold short2026-10-05: 39% of volume sold short2026-10-06: 46% of volume sold short2026-10-07: 40% of volume sold short2026-10-08: 31% of volume sold short2026-10-09: 34% of volume sold short2026-10-12: 54% of volume sold short2026-10-13: 56% of volume sold short2026-10-14: 38% of volume sold short2026-10-15: 27% of volume sold short2026-10-16: 33% of volume sold short2026-10-19: 54% of volume sold short2026-10-20: 43% of volume sold short2026-10-21: 54% of volume sold short2026-10-22: 48% of volume sold short2026-10-23: 58% of volume sold short2026-10-26: 52% of volume sold short2026-10-27: 39% of volume sold short2026-10-28: 35% of volume sold short2026-10-29: 42% of volume sold short2026-10-30: 34% of volume sold short2026-11-02: 40% of volume sold short2026-11-03: 34% of volume sold short2026-11-04: 18% of volume sold short2026-11-05: 22% of volume sold short2026-11-06: 42% of volume sold short2026-11-09: 42% of volume sold short2026-11-10: 51% of volume sold short2026-11-11: 39% of volume sold short2026-11-12: 38% of volume sold short2026-11-13: 43% of volume sold short2026-11-16: 40% of volume sold short2026-11-17: 31% of volume sold short2026-11-18: 31% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 31%20-day average: 36%Prior 2 months: 33%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Insiders at Bio-Techne

InsiderBoughtSoldLast filingPast buys beat S&PScore
Amy E. HerrDirector — $437K Nov 2, 2026 — —
James HippelCFO — — Nov 3, 2026 — —
Kim KeldermanCEO — — Nov 3, 2026 — —
William GeistPresident — — Nov 2, 2026 — —
Shane BohnenGeneral Counsel — — Nov 2, 2026 — —
Robert V. BaumgartnerDirector — — Nov 2, 2026 — —
Julie L. BushmanDirector — — Nov 2, 2026 — —
John L. HigginsDirector — — Nov 2, 2026 — —
Joseph D. KeeganDirector — — Nov 2, 2026 — —
Judith V. KlimovskyDirector — — Nov 2, 2026 — —
Alpna SethDirector — — Nov 2, 2026 — —
Rupert VesseyDirector — — Nov 2, 2026 — —
Steven C. CrousePresident — — Aug 18, 2026 — —
Matthew McManusPresident — — Feb 3, 2026 1 of 1 —

Board links: companies that share insiders with TECH

Directors and executives who filed Form 4s for TECH and another company in the last 12 months.

See the map →
  • KROSKeros Therapeutics Alpna Seth Director here · Director at KROS · latest filing Nov 2, 2026
  • OABIOmniAb John L. Higgins Director here · Director at OABI · latest filing Nov 2, 2026
  • PSXPhillips 66 Julie L. Bushman Director here · Director at PSX · latest filing Nov 2, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

TECH stock: common questions

Are Bio-Techne insiders buying TECH stock?

No. No Bio-Techne insider reported an open-market purchase of TECH in the past 12 months.

Are Bio-Techne insiders selling TECH stock?

1 insider reported sales worth $437K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is TECH's P/E ratio?

TECH trades at about 66.8 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is TECH's 52-week range?

Over the past year TECH has traded between $43.17 and $72.80. It last closed at $72.71 on Nov 19, 2026.